Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients
Clinical trial NCT02912754 · UNKNOWN
Trial details
- NCT number
- NCT02912754
- Sponsor
- Sunnybrook Health Sciences Centre
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-01
- Primary completion
- 2018-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.